Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States

Agriculture & Biology

• influenza vaccines 100%
• inactivated vaccines 88%
• live vaccines 82%
• cost effectiveness 72%
• influenza 22%
• vaccines 12%
• health services 10%
• quality-adjusted life year 8%
• advisory committees 7%
• cost estimates 6%
• clinical trials 5%
• immunization 4%
• vaccination 4%
• methodology 1%

Medicine & Life Sciences

• Inactivated Vaccines 83%
• Attenuated Vaccines 83%
• Influenza Vaccines 76%
• Cost-Benefit Analysis 58%
• Child 29%
• Human Influenza 17%
• Costs and Cost Analysis 14%
• Vaccines 10%
• Cost Savings 5%
• Quality-Adjusted Life Years 5%
• Advisory Committees 5%
• Health Care Costs 4%
• Immunization 4%
• Vaccination 3%
• Parents 3%
• Randomized Controlled Trials 3%
• Clinical Trials 3%
• Delivery of Health Care 2%

Social Sciences

• contagious disease 66%
• costs 38%
• illness 6%
• life years 4%
• vaccination 4%
• Clinical Trials 3%
• savings 3%
• productivity 3%
• Healthcare 2%
• health care 2%
• literature 1%